Your browser doesn't support javascript.
loading
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer.
Nakabayashi, Mari; Werner, Lilian; Courtney, Kevin D; Buckle, Geoffrey; Oh, William K; Bubley, Glen J; Hayes, Julia H; Weckstein, Douglas; Elfiky, Aymen; Sims, Danny M; Kantoff, Philip W; Taplin, Mary-Ellen.
Affiliation
  • Nakabayashi M; Lank Center for Genitourinary Oncology, Department of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.
BJU Int ; 110(11): 1729-35, 2012 Dec.
Article in En | MEDLINE | ID: mdl-22928480
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Antineoplastic Agents Limits: Aged / Humans / Male / Middle aged Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2012 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Antineoplastic Agents Limits: Aged / Humans / Male / Middle aged Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2012 Document type: Article Affiliation country: